These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6263058)

  • 21. Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy.
    Connell JM; Hilditch TE; McCruden DC; Robertson J; Alexander WD
    Eur J Nucl Med; 1984; 9(10):464-6. PubMed ID: 6510423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis.
    Goolden AW; Stewart JS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):217-22. PubMed ID: 3708873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975.
    Holm LE
    J Nucl Med; 1982 Feb; 23(2):108-12. PubMed ID: 7057249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid function and mortality in patients treated for hyperthyroidism.
    Franklyn JA; Sheppard MC; Maisonneuve P
    JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radioisotope studies in primary hypothyroidism].
    Eheiretova E; Peshev N; Ivanov Zh
    Vutr Boles; 1974; 13(4):58-61. PubMed ID: 4446599
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypothyroidism caused by radioiodine therapy].
    Miclulţia M; Derevenco V; Holan T
    Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
    [No Abstract]   [Full Text] [Related]  

  • 27. Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism.
    Alevizaki CC; Alevizaki-Harhalaki MC; Ikkos DG
    Eur J Nucl Med; 1985; 10(9-10):450-4. PubMed ID: 4006987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 131I treated hypothyroidism and thyroid antibody levels.
    Vejjajiva S; Poshyachinda M; Yenbutra D
    J Med Assoc Thai; 1979 Feb; 62(2):51-3. PubMed ID: 762484
    [No Abstract]   [Full Text] [Related]  

  • 29. [Application of a Markov model to the follow-up of hyperthyroid patients treated with radioactive iodine].
    Barberger-Gateau P; Commenges D; Salamon R; Commenges-Ducos M
    Med Inform (Lond); 1983; 8(2):83-7. PubMed ID: 6865567
    [No Abstract]   [Full Text] [Related]  

  • 30. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
    Kennedy JS; Thomson JA
    J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism.
    Safa AM; Schumacher OP; Rodriguez-Antunez A
    N Engl J Med; 1975 Jan; 292(4):167-71. PubMed ID: 45842
    [No Abstract]   [Full Text] [Related]  

  • 32. [131I therapy in hyperthyroidism. Results of treatment from 1960-1974].
    Heinze HG; Schenk F
    Nuklearmedizin; 1977 Feb; 16(1):1-12. PubMed ID: 846862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
    Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
    Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
    J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of hypothyroidism after radioactive iodine (131I) therapy for autonomous hyperfunctioning thyroid nodule evaluated by means of life-table method.
    Fontana B; Curti G; Biggi A; Fresco G
    J Nucl Med Allied Sci; 1980; 24(1-2):85-91. PubMed ID: 7205395
    [No Abstract]   [Full Text] [Related]  

  • 37. [Short-term results of treatment with 131I in patients with multinodular goiter: effect of the associated degree of hyperthyroidism and other variables].
    Boj Carceller D; Liévano Segundo P; Navarro Beltrán P; Sanz París A; de Castro Hernández P; Monreal Villanueva M; Abós Olivares D
    Rev Esp Med Nucl; 2011; 30(3):156-61. PubMed ID: 21481495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
    J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
    [No Abstract]   [Full Text] [Related]  

  • 39. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

  • 40. Ablative radioiodine therapy for hyperthyroidism: long term follow up study.
    Kendall-Taylor P; Keir MJ; Ross WM
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):361-3. PubMed ID: 6432100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.